Vascular Solutions Inc (VASC)

56.00
0.00 (0.00)
NASDAQ : Health Care
Prev Close 56.00
Open 56.00
Day Low/High 55.95 / 56.00
52 Wk Low/High 24.34 / 44.27
Volume 1.21M
Avg Volume 260.50K
Exchange NASDAQ
Shares Outstanding 17.57M
Market Cap 983.83M
EPS 0.60
P/E Ratio 81.16
Div & Yield N.A. (N.A)

Latest News

Vascular Solutions Stock Sees Short Interest Plummet 78.4%

Vascular Solutions Stock Sees Short Interest Plummet 78.4%

The most recent short interest data has been released for the 12/15/2016 settlement date, which shows a 774,248 share decrease in total short interest for Vascular Solutions Inc , to 213,018, a decrease of 78.42% since 11/30/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Vascular...

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of Vascular Solutions, Inc. To Teleflex Incorporated For $56 Per Share Is Fair To Shareholders

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of Vascular Solutions, Inc. To Teleflex Incorporated For $56 Per Share Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Vascular Solutions, Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Vascular...

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of Vascular Solutions, Inc. To Teleflex Incorporated For $24 Per Share Is Fair To Shareholders -- VASC

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of Vascular Solutions, Inc. To Teleflex Incorporated For $24 Per Share Is Fair To Shareholders -- VASC

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Vascular Solutions, Inc.

VASCULAR SOLUTIONS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Teleflex Incorporated

VASCULAR SOLUTIONS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Teleflex Incorporated

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Vascular...

Midday Report: Pandora Jumps on Sale Reports; Banks Reverse Course

Midday Report: Pandora Jumps on Sale Reports; Banks Reverse Course

Stocks were mostly higher after U.S. jobs gains in November solidified the chances of an interest rate hike in December.

Medical Device Companies Vascular Solutions, Teleflex Agree to $1 Billion Merger

Medical Device Companies Vascular Solutions, Teleflex Agree to $1 Billion Merger

Teleflex has agreed to acquire the medical device company for about $1 billion after the target and its CEO were acquitted in a criminal case earlier in the year.

VASC Crosses Above Average Analyst Target

VASC Crosses Above Average Analyst Target

In recent trading, shares of Vascular Solutions Inc have crossed above the average analyst 12-month target price of $52.25, changing hands for $52.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

VASC Crosses Above Average Analyst Target

VASC Crosses Above Average Analyst Target

In recent trading, shares of Vascular Solutions Inc have crossed above the average analyst 12-month target price of $45.00, changing hands for $46.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.